NIRS and Doppler to Predict NEC in Risk Neonates
NCT: NCT01833000 · TERMINATED
NCT IDNCT01833000
StatusTERMINATED
Start Date2013-02
Completion2016-03-01
SponsorUniversity Hospital, Montpellier (OTHER)
First posted
Last updated
Brief Summary
The main objective is to evaluate the interest of cerebro-splanchnic oxygenation ratio (CSOR) for early diagnosis of necrotizing enterocolitis (NEC) in neonates with rectal bleeding and/or abdominal distension. CSOR will be determined using near infrared spectroscopy (NIRS).
Frequently Asked Questions
What is NIRS and Doppler to Predict NEC in Risk Neonates?
NIRS and Doppler to Predict NEC in Risk Neonates is a clinical trial registered under NCT01833000. Current status: TERMINATED.
What is the status of NCT01833000?
The current status of NCT01833000 (NIRS and Doppler to Predict NEC in Risk Neonates) is: TERMINATED.
When did NIRS and Doppler to Predict NEC in Risk Neonates start?
NIRS and Doppler to Predict NEC in Risk Neonates started on 2013-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.